Pravastatin Sodium 80 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the comparative bioavailability between
pravastatin sodium 80 mg tablets (Distributed by Teva Pharmaceuticals, USA) and Pravachol® 80
mg tablets (Bristol Myers Squibb, USA), after a single-dose in healthy subjects under fasting
conditions.